Clinical and dEmographic chaRacteristics of Patients With Frequent COPD Exacerbations and Evaluation of Therapeutic Approaches in Treatment in RussiA

Status: Recruiting
Location: See all (6) locations...
Study Type: Observational
SUMMARY

This Study is a multicenter, non-interventional, observational, ambispective (retrospective-prospective) study to evaluate clinical and demographic characteristics, approaches to therapy in outpatients with COPD and frequent exacerbations in the Russian Federation. Planned number of Study site is 35 outpatient centers with experience of treatment of COPD with frequency exacerbations in about 30 regions in Russia.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 100
Healthy Volunteers: f
View:

• Age ≥ 18 years at the time of inclusion;

• Signed and dated written informed consent in accordance with ICH-GCP and local law prior to inclusion in the study;

• Patients with diagnosed moderate-to-severe COPD (see comments below);

• ≥2 moderate or ≥1 severe COPD exacerbations in previous 52 weeks (see comments below);

• Patients have been receiving two inhaled maintenance therapies (LABA/LAMA, ICS/LABA, ICS/LAMA) for at least 6 weeks prior to inclusion.

Locations
Other Locations
Russian Federation
Research site
RECRUITING
Ivanovo
Research site
RECRUITING
Moscow
Research site
RECRUITING
Saint Petersburg
Research site OOO Energy of health
RECRUITING
Saint Petersburg
Research site
RECRUITING
Voronezh
Research site
RECRUITING
Yekaterinburg
Contact Information
Primary
AstraZeneca Clinical Study Information Center
information.center@astrazeneca.com
1-877-240-9479
Time Frame
Start Date: 2024-12-16
Estimated Completion Date: 2026-06-30
Participants
Target number of participants: 2000
Sponsors
Leads: AstraZeneca

This content was sourced from clinicaltrials.gov